Pfizer Zithromax
Executive Summary
Pfizer is preparing a supplemental NDA for a single dose regimen of Zithromax (azithromycin) in children with acute otitis media, company tells Goldman Sachs conference June 13. Zithromax oral suspension is currently approved for pediatric acute otitis media in a five-day regimen